These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12492979)

  • 1. Extranodal Rosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin.
    Chang LY; Kuo TT; Chan HL
    Int J Dermatol; 2002 Dec; 41(12):888-91. PubMed ID: 12492979
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) with cutaneous and ocular involvement: a case report.
    Wong HC; Wright JE; Harry J
    Eye (Lond); 1989; 3 ( Pt 6)():849-53. PubMed ID: 2630369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): diagnosis by fine-needle aspiration.
    Trautman BC; Stanley MW; Goding GS; Rosai J
    Diagn Cytopathol; 1991; 7(5):513-6. PubMed ID: 1954831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purely cutaneous Rosai-Dorfman disease].
    Plettenberg H; Artik S; Kuhn A; Megahed M; Ruzicka T; Kruse R
    Hautarzt; 2004 Oct; 55(10):969-71. PubMed ID: 15351867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngeal Rosai-Dorfman Disease (Sinus Histiocytosis with Massive Lymphadenopathy): A Retrospective Study of 5 Cases.
    Niu Y; Li Y; Wang J; Jin X; Yang D; Huo H; Li W
    Biomed Res Int; 2017; 2017():8521818. PubMed ID: 28770226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of cutaneous Rosai-Dorfman disease presenting with auricular enlargement as the first manifestation.
    Gan L; Liu WD; Yu WT; Sun JF; Jiang YQ
    Indian J Dermatol Venereol Leprol; 2019; 85(5):518-522. PubMed ID: 31290464
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism.
    Salim A; Williamson M; Barker F; Hughes J
    Clin Exp Dermatol; 2002 Jun; 27(4):277-9. PubMed ID: 12139669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Rosai-Dorfman Disease: A Novel Clinical Presentation.
    Conde JM; Kim AY; de Miguel R; Nousari CH
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):655-657. PubMed ID: 29602416
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of histiocytic lymphophagocytic panniculitis (Rosai-Dorfman disease) with positive autoantibodies.
    Wang F; Chen X; Wu W; Wang Z; Han J
    J Dtsch Dermatol Ges; 2015 Apr; 13(4):334-6. PubMed ID: 25819246
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous Rosai-Dorfman disease of the face with a leonine appearance: successful response to dapsone.
    Lee YI; Kim SK; Oh SH; Kim DY
    Eur J Dermatol; 2018 Apr; 28(2):255-256. PubMed ID: 29400286
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Rosai-Dorfman disease with oral bexarotene: a case series.
    Geller S; Busam K; Hamlin PA; Moskowitz AJ; Horwitz SM; Myskowski PL
    J Dermatolog Treat; 2019 Aug; 30(5):503-505. PubMed ID: 30244619
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous rosai-dorfman disease and morphea: coincidence or association?
    Chappell JA; Burkemper NM; Frater JL; Hurley MY
    Am J Dermatopathol; 2009 Jul; 31(5):487-9. PubMed ID: 19542928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Rosai-Dorfman disease.
    Parrent T; Clark T; Hall D
    Cutis; 2012 Nov; 90(5):237-8. PubMed ID: 23270193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose weekly methotrexate used to treat cutaneous Rosai-Dorfman disease.
    Subash JJ; Kesty C; Kesty KR; Asgari M; Jorizzo J
    Clin Exp Dermatol; 2018 Oct; 43(7):849-851. PubMed ID: 29869440
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases.
    Wei C; Zhou DB
    Hematology; 2021 Dec; 26(1):552-555. PubMed ID: 34348601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous involvement of pre-existing Rosai-Dorfman disease via post-herpetic isotopic response.
    Malviya N; Marzuka A; Maamed-Tayeb M; Le L; Vandergriff T
    J Cutan Pathol; 2016 Dec; 43(12):1211-1214. PubMed ID: 27611178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosai-Dorfman disease with isolated laryngeal involvement.
    Illing EA; Halum SL
    Ear Nose Throat J; 2012 Oct; 91(10):439-40. PubMed ID: 23076853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngeal obstruction and hoarseness associated with Rosai-Dorfman disease.
    Cossor F; Al-Khater AH; Doll DC
    J Clin Oncol; 2006 Apr; 24(12):1953-5. PubMed ID: 16622273
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple nodules and plaques on the face and trunk. Cutaneous Rosai-Dorfman disease (RDD).
    Wartman DG; Perry A; Werchniak AE
    Arch Dermatol; 2006 Nov; 142(11):1501-6. PubMed ID: 17116845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.